Epidemiology of Sjögren’s: A Systematic Literature Review Eleanor ThurtleAlice GrosjeanPushpendra Goswami Review Open access 10 November 2023 Pages: 1 - 17
The Role of Early Treatment in the Management of Axial Spondyloarthritis: Challenges and Opportunities Daniele MauroGiulio ForteFrancesco Ciccia Review Open access 18 December 2023 Pages: 19 - 34
Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials Gustavo CiteraRakesh JainDario Ponce de Leon Original Research Open access 05 November 2023 Pages: 35 - 50
Endovascular Interventional Procedure is a Significant Risk Factor of Postsurgical Gout: A Retrospective Cohort Study Shunjie HuZitao WangXiaoyong Lu Original Research Open access 06 November 2023 Pages: 51 - 60
Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis Jeffrey R. CurtisVibeke StrandViatcheslav R. Akmaev Original Research Open access 10 November 2023 Pages: 61 - 77
Efficacy, Safety and the Lymphocyte Subset Changes of Low-Dose IL-2 in Patients with Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis Qinyi SuXinmiao WangSheng-Xiao Zhang Original Research Open access 19 November 2023 Pages: 79 - 96
Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis Andrea Rubbert-RothAdriana M. KakehasiJeffrey R. Curtis Original Research Open access 20 November 2023 Pages: 97 - 112
Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database Analysis Elena Garal-PantalerMichael SchultzeJacob N. Hunnicutt Original Research Open access 25 November 2023 Pages: 113 - 127
Cross-Sectional and Longitudinal Associations of Comorbidities with Knee Symptoms and Radiographic Abnormalities of Osteoarthritis Xiaoxi LiFeng PanGuoqi Cai Original Research Open access 18 November 2023 Pages: 129 - 142
Adalimumab Effectively Decreases Inflammation Downstream of TNFα Signaling in Synoviocytes from Extended Oligoarticular Juvenile Idiopathic Arthritis Megan M. SimondsSamuel T. FreerAnneMarie C. Brescia Original Research Open access 09 December 2023 Pages: 143 - 155
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years Christina Charles-SchoemanJon T. GilesIain B. McInnes Original Research Open access 05 January 2024 Pages: 157 - 175
Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis Jeffrey R. CurtisPaul EmeryGerd Rüdiger Burmester Brief Report Open access 06 December 2023 Pages: 177 - 189
Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection Xiaowei ZhangYifei LiGuihong Wang Brief Report Open access 04 January 2024 Pages: 191 - 200
Characteristics of COVID-19 and Impact of Disease Activity in Patients with Adult-Onset Still’s Disease Xinyue HongXiaoming WangHuihui Chi Brief Report Open access 06 January 2024 Pages: 201 - 212
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA) Siegfried WassenbergRolf RauPeter-Andreas Löschmann Correction Open access 20 September 2023 Pages: 213 - 213
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA) Siegfried WassenbergRolf RauPeter-Andreas Löschmann Correction Open access 29 November 2023 Pages: 215 - 215
Correction: Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry Jeffrey R. CurtisHuifeng YunErnest Choy Correction Open access 13 November 2023 Pages: 217 - 217
Correction: Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study Christopher F. BellJake ChungBernard Rubin Correction Open access 23 November 2023 Pages: 219 - 219
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis Gerd R. BurmesterLaura C. CoatesCassandra Kinch Correction Open access 02 December 2023 Pages: 221 - 222
Correction: Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate Yoshiya TanakaPeter C. TaylorTsutomu Takeuchi Correction Open access 20 November 2023 Pages: 223 - 224
Correction: Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis Jessica A. WalshChristopher D. SafforeAndrew Ostor Correction Open access 29 November 2023 Pages: 225 - 226
